Kukbo

Kukbo is a South Korean company that has transitioned from a traditional logistics and transportation focus into the healthcare and biotechnology sectors. The company's life sciences division is primarily driven by strategic investments and exclusive distribution rights for innovative therapeutics, most notably through a partnership with RedHill Biopharma. This collaboration grants Kukbo rights to distribute Opaganib and RHB-107, which are being developed for COVID-19 and various oncology indications, in South Korea and other Asian markets. Additionally, Kukbo manufactures and distributes medical supplies, including high-quality masks and diagnostic equipment. Listed on the KOSPI, the company aims to integrate its established logistics network with its growing pharmaceutical portfolio to become a major healthcare player in the region.